Skip to content
Tech News
← Back to articles

VC-hosted peptide event spotlights push for US-based peptide manufacturing

read original more articles
GoKawiil Brief

Three Gen Z venture capitalists hosted a black-tie peptide event aboard the historic SS Jeremiah O'Brien ship in San Francisco, drawing roughly 150 attendees. Guests sampled a topical GHK-Cu cream and three sublingual peptide strips from startup Afterglow, with organizers using the WWII vessel as a symbol for American industrial capability and arguing the pharmaceutical supply chain should be based domestically. The event coincided with a recent interim policy from the Department of Health and Human Services allowing certain unapproved peptides to be used in compounding, a decision that FDA career scientists have not endorsed.

Why It Matters

GoKawiil's interpretation of the reporting above, not reported fact.

The gathering reflects growing investor interest in peptides, a category that has largely operated in a gray market with limited oversight on sourcing and manufacturing. The HHS policy shift could reshape how peptides reach consumers by bypassing standard clinical trials, which some industry experts warn undermines established safety and efficacy testing. This suggests a broader tension between venture-backed enthusiasm for unproven wellness products and regulatory caution rooted in insufficient scientific evidence.

Key Takeaways

Source: theverge.com — Victoria Song, 2026-11-12

Published there as: “Meet the people who want peptides to be made in America”

Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.
Keep reading
peptides 14 briefs →